134 related articles for article (PubMed ID: 34215839)
1. Warfarin maintenance dose prediction for Chinese after heart valve replacement by a feedforward neural network with equal stratified sampling.
Ma W; Li H; Dong L; Zhou Q; Fu B; Hou JL; Wang J; Qin W; Chen J
Sci Rep; 2021 Jul; 11(1):13778. PubMed ID: 34215839
[TBL] [Abstract][Full Text] [Related]
2. The Prediction Model of Warfarin Individual Maintenance Dose for Patients Undergoing Heart Valve Replacement, Based on the Back Propagation Neural Network.
Li Q; Wang J; Tao H; Zhou Q; Chen J; Fu B; Qin W; Li D; Hou J; Chen J; Zhang WH
Clin Drug Investig; 2020 Jan; 40(1):41-53. PubMed ID: 31586305
[TBL] [Abstract][Full Text] [Related]
3. A prediction study of warfarin individual stable dose after mechanical heart valve replacement: adaptive neural-fuzzy inference system prediction.
Tao H; Li Q; Zhou Q; Chen J; Fu B; Wang J; Qin W; Hou J; Chen J; Dong L;
BMC Surg; 2018 Feb; 18(1):10. PubMed ID: 29448930
[TBL] [Abstract][Full Text] [Related]
4. An Adapted Neural-Fuzzy Inference System Model Using Preprocessed Balance Data to Improve the Predictive Accuracy of Warfarin Maintenance Dosing in Patients After Heart Valve Replacement.
Gu ZC; Huang SR; Dong L; Zhou Q; Wang J; Fu B; Chen J
Cardiovasc Drugs Ther; 2022 Oct; 36(5):879-889. PubMed ID: 33877502
[TBL] [Abstract][Full Text] [Related]
5. Warfarin maintenance dose Prediction for Patients undergoing heart valve replacement- a hybrid model with genetic algorithm and Back-Propagation neural network.
Li Q; Tao H; Wang J; Zhou Q; Chen J; Qin WZ; Dong L; Fu B; Hou JL; Chen J; Zhang WH
Sci Rep; 2018 Jun; 8(1):9712. PubMed ID: 29946101
[TBL] [Abstract][Full Text] [Related]
6. Use of artificial neural network to predict warfarin individualized dosage regime in Chinese patients receiving low-intensity anticoagulation after heart valve replacement.
Zhou Q; Kwong J; Chen J; Qin W; Chen J; Dong L;
Int J Cardiol; 2014 Oct; 176(3):1462-4. PubMed ID: 25164187
[No Abstract] [Full Text] [Related]
7. Warfarin Therapy After Mechanical Valve Replacement: A Tool for Predicting Bleeding Events.
Jang I; Choo S; Kim K
J Heart Valve Dis; 2017 Mar; 26(2):215-233. PubMed ID: 28820554
[TBL] [Abstract][Full Text] [Related]
8. VKORC1 -1639G/A and 1173 C/T Genetic Polymorphisms Influence Individual Differences in Warfarin Maintenance Dose.
Li Y; Zhu J; Ding J
Genet Test Mol Biomarkers; 2015 Sep; 19(9):488-93. PubMed ID: 26167638
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study.
Durães AR; de Souza Lima Bitar Y; Filho JAL; Schonhofen IS; Camara EJN; Roever L; Cardoso HEDP; Akrami KM
Drugs R D; 2018 Dec; 18(4):303-308. PubMed ID: 30293126
[TBL] [Abstract][Full Text] [Related]
10. Applying an artificial neural network to warfarin maintenance dose prediction.
Solomon I; Maharshak N; Chechik G; Leibovici L; Lubetsky A; Halkin H; Ezra D; Ash N
Isr Med Assoc J; 2004 Dec; 6(12):732-5. PubMed ID: 15609884
[TBL] [Abstract][Full Text] [Related]
11. Predicting Range of Initial Warfarin Dose Based on Pharmacometabolomic and Genetic Inputs.
Huang Q; Cao L; Luo N; Qian H; Wei M; Xue L; Zhou Q; Zou B; Tan L; Chu Y; Ma X; Wang C; Wu H; Zhang L; Sun L; Li D; Fan X; Miao L; Zhou G
Clin Pharmacol Ther; 2021 Dec; 110(6):1585-1594. PubMed ID: 34460938
[TBL] [Abstract][Full Text] [Related]
12. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.
Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ
J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309
[TBL] [Abstract][Full Text] [Related]
13. Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing.
Meijer K; Kim YK; Schulman S
Thromb Res; 2010 Mar; 125(3):224-9. PubMed ID: 19336266
[TBL] [Abstract][Full Text] [Related]
14. Management of pregnant women with artificial heart valves: inconsistency in ESC publications.
Mischke K
Eur Heart J; 2007 Oct; 28(19):2419; author reply 2419-20. PubMed ID: 17709557
[No Abstract] [Full Text] [Related]
15. De Ritis ratio as a significant prognostic factor of international normalized ratio ≥4 in the initial 10 days of warfarin therapy.
Cao Y; Chen G; Li H; Liu Y; Tao Z; Li L; Chen W; Xu Y; Chen X
Biomark Med; 2019 Dec; 13(18):1599-1607. PubMed ID: 31660758
[No Abstract] [Full Text] [Related]
16. Effects of single nucleotide polymorphisms in c-Myc on stable warfarin doses in patients with cardiac valve replacements.
Lee KE; Chang BC; Park S; Gwak HS
Pharmacogenomics; 2015; 16(10):1101-8. PubMed ID: 26249541
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
Meijer K; Kim YK; Carter D; Schulman S
Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Warfarin Requirements in Post-cardiac Surgery Patients: Valve Replacement Versus Non-valve Replacement.
Olson LM; Nei AM; Joyce DL; Ou NN; Dierkhising RA; Nei SD
Am J Cardiovasc Drugs; 2018 Jun; 18(3):223-229. PubMed ID: 29327158
[TBL] [Abstract][Full Text] [Related]
19. DBCSMOTE: a clustering-based oversampling technique for data-imbalanced warfarin dose prediction.
Tao Y; Zhang Y; Jiang B
BMC Med Genomics; 2020 Oct; 13(Suppl 10):152. PubMed ID: 33087117
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Performance of the Warfarin Pharmacogenetics Algorithms in Patients with Surgery of Heart Valve Replacement and Heart Valvuloplasty.
Xu H; Su S; Tang W; Wei M; Wang T; Wang D; Ge W
Thromb Res; 2015 Sep; 136(3):552-9. PubMed ID: 26188922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
